Share

    


In This Section

Home / Learn / Precision Medicine / Project ECHO®: Tele-mentoring to Manage Immune-related Adverse Events in Patients Receiving Cancer Immunotherapies

Project ECHO®: Tele-mentoring to Manage Immune-related Adverse Events in Patients Receiving Cancer Immunotherapies

Could you benefit from expert advice on the optimal management of Immune-related Adverse Events (irAEs)? If so, please join ACCC and Boston University for monthly tele-mentoring sessions where you can receive guidance on clinical cases and have your questions answered by expert faculty.

We welcome you to submit unidentified clinical case scenarios for each of the tumor-board style discussions.  Submission instructions will be available upon registration.

Target Audience: Oncologists, oncology advanced practice providers (nurse practitioners, physician assistants), oncology pharmacists, oncology nurses, and other healthcare professionals (HCPs) involved in treating patients with cancer immunotherapies

When: Third Tuesday of every month from 3:00 – 4:00 PM ET, beginning September 20, 2022. Participants can join the virtual program at any time.

September 20, 2022
Cardiology
February 21, 2023
Neurology
October 18, 2022
Gastroenterology
March 21, 2023
Hepatology
November 15, 2022
Endocrinology
April 18, 2023
Dermatology
January 17, 2023
Rheumatology
May 16, 2023
Pulmonology

Free Registration

Registration Instructions

A Zoom link will be provided upon registration. Please click the “Add to Calendar” option after registering to add this series on your calendar. To join each session, use the Zoom link in the calendar invitation so you do not have to complete the registration form again.

Questions? Contact Mary Stanley, Program Manager.

Learning Objectives

At the end of this educational activity, participants will be able to:

  • Apply evidence-based practices for the monitoring and management of irAEs in patients receiving cancer immunotherapies
  • Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAEs in patients receiving cancer immunotherapies
  • Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies

Steering Committee

Jocelyn E. Mohs, PharmD, BCOP 
Director of Pharmacy
Sanford Medical Center, Fargo
Fargo, North Dakota

Ryan M. Weight DO, MS
Medical Director
The Melanoma and Skin Cancer Institute
Denver, CO

Laura S. Wood RN, MSN, OCN
Oncology Nurse Specialist
Medina, Ohio

Hosted by OncoLens. This activity will be CME/CPE/CNE-certified.


Our Supporter

Oncolens-215x80
Hosted by OncoLens.